Asiatic Laboratories Ltd

DHA:ASIATICLAB (Bangladesh)  
BDT 63.10 (-2.92%) May 23
Market Cap:
BDT 7.72B ($ 65.92M)
Enterprise V:
BDT 7.72B ($ 65.92M)
Volume:
532.91K
Avg Vol (2M):
4.81M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Asiatic Laboratories Ltd ( DHA:ASIATICLAB ) from 2024 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Asiatic Laboratories stock (DHA:ASIATICLAB) PE ratio as of May 26 2024 is 9999. More Details

Asiatic Laboratories Ltd (DHA:ASIATICLAB) PE Ratio (TTM) Chart

To

Asiatic Laboratories Ltd (DHA:ASIATICLAB) PE Ratio (TTM) Historical Data

Total 0
  • 1
Asiatic Laboratories PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Asiatic Laboratories Ltd (DHA:ASIATICLAB) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Compare
Compare
Traded in other countries / regions
ASIATICLAB.Bangladesh
IPO Date
2024-03-06
Description
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.